Results 241 to 250 of about 51,825 (261)
Some of the next articles are maybe not open access.
NTRK fusion-positive cancers and TRK inhibitor therapy
Nature Reviews Clinical Oncology, 2018Emiliano Cocco +2 more
exaly
The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy
Nature Reviews Cancer, 2019Jonathan J Havel +2 more
exaly
Non-muscle myosin II takes centre stage in cell adhesion and migration
Nature Reviews Molecular Cell Biology, 2009Miguel Vicente-Manzanares +1 more
exaly
AKT answer relating to cardiac myosin inhibitor interactions
InnovAiT: Education and inspiration for general practiceopenaire +1 more source
AKT question relating to cardiac myosin inhibitor interactions
InnovAiT: Education and inspiration for general practiceopenaire +1 more source
Regulation of cardiac hypertrophy by intracellular signalling pathways
Nature Reviews Molecular Cell Biology, 2006Joerg Heineke, Jeffery D Molkentin
exaly
Monitoring immune-checkpoint blockade: response evaluation and biomarker development
Nature Reviews Clinical Oncology, 2017Mizuki Nishino +2 more
exaly
Targeted agents and immunotherapies: optimizing outcomes in melanoma
Nature Reviews Clinical Oncology, 2017Jason J Luke +2 more
exaly
Appraising iniparib, the PARP inhibitor that never was—what must we learn?
Nature Reviews Clinical Oncology, 2013Joaquin Mateo +2 more
exaly
Oncologic emergencies: Pathophysiology, presentation, diagnosis, and treatment
Ca-A Cancer Journal for Clinicians, 2011exaly